Schroeder Martin 4/A
4/A · Genesis Biopharma, Inc · Filed Mar 9, 2012
Insider Transaction Report
Form 4/AAmended
Genesis Biopharma, IncGNBP.OB
Schroeder Martin
Director
Transactions
- Purchase
Common Stock
2011-08-22$0.00/sh+1,000,000$1,000→ 1,000,000 total(indirect: See footnote.)
Footnotes (1)
- [F1]Mr. Schroeder is Executive Vice President and Managing Director of Emmes Group Consulting LLC.